NewsRx

Search our medical news database

Drug Law Weekly

Susan Hasty, Publisher

Table of Contents . . . February 1st, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Drug Law Weekly | Other Publications

Agilent Technologies, Inc. - Chip maker acquires gene regulation analysis company

American Medical Systems Holdings, Inc. - Medicare payment value corrected for Her Option cryoablation therapy

Correctional Health - Jury awards $1.2 million to two men sickened in jail infection

Genaissance Pharmaceuticals, Inc. - Patent granted for methods to correlate genetics with drug safety and efficacy

Information Technology - DecisionPath inks contract with U.S. Social Security Administration

Insmed Incorporated - Biopharmaceutical company comments on recent actions by Tercica, Inc.

Legal Issues - Wyoming advocacy group sues state over treatment of mentally ill patients

NMT Medical, Inc. - Patient enrollment for migraine intervention initiated

OccuLogix, Inc. - Pharma company enrolls patients in age-related macular degeneration trial

Oscient Pharmaceuticals Corporation - Pharma company announces new hires

Personnel - Former FDA staffers Dan Troy and Coleen Klasmeier join law firm

SCOLR Pharma, Inc. - Pharma company names new hire to newly created positions

Vasomedical, Inc. - Medicare payment for EECP therapy for cardiovascular disease increases

Winstead Sechrest & Minick P.C - Texas law firm launches biotechnology practice, hires 4 pharma legal experts

ARUP Inst. for Clinical & Experimental Pathology - Microsphere-based immunoassay suitable for detection of ENA autoantibodies

Acambis plc - Fast track status granted for ACAM2000 smallpox vaccine

Adolor Corporation - U.S. FDA seeks more data on phase III trial of alvimopan in postoperative ileus

Aerocrine, Inc. - Aerocrine NO monitor cleared by U.S. FDA for monitoring asthma therapy

Alnylam Pharmaceuticals, Inc. - GeneCare Research Institute granted licenses to IP for RNAi therapeutics

American College of Sports Medicine, Philadelpia - Drug prophylaxis recommended even for physically active postmenopausal women

Artes Medical Inc. - Request granted for re-examination of competitor's injectable skin filler patent

AstraZeneca - Council recommends approval of Crestor in Japan

AtheroGenics, Inc. - Pharmaceutical firm announces proposed offering of notes

Avanir Pharmaceuticals - Orally active asthma/allergy drug candidate subject of journal article

Avant Immunotherapeutics - $2M milestone payment issued for marketing approval of Rotarix

Ben Gurion University Negev, Beer Sheva - Ciliary protein phosphorylation regulated by Ca2+ and nitric oxide

BioAlliance Pharma - Preliminary phase III data reported on miconazole Lauriad

BioDelivery Sciences International, Inc. - Bioral drug delivery may reduce GI damage caused by NSAIDs, aspirin

BioXell, Milan - Antigen-based immuno-intervention in human autoimmune diseases reviewed

Biosite Incorporated - PMA application filed for Triage Stroke Panel

Biotechnology Industry Organization - Former governor James Greenwood assumes presidency of biotechnology association

Brigham & Women's Hospital, Boston - LIR3 counter-regulatory for both adaptive and innate receptors

Brown University - Serotonin receptor antagonists may be useful in the treatment of PML

Brown University, Providence - High-affinity antibody steers therapy to hepatocellular carcinoma

CHU Laval, Quebec City - Phi C31 integrase and nucleofection create stable transgene expression

CSIRO - Link between insulin receptor and epidermal growth factor receptors reviewed

California Walnuts - Walnut foundation comments on new U.S. Dietary Guidelines

Cancer Care Consultants - Cancer center installs optical tracking technology for radiation treatment

CardioGenesis Corporation - FDA approves laser for transmyocardial revascularization

Cel-Sci Corp. - Phase III trial application filed for Multikine

Centocor, Inc. - Effect of site-specific pegylation on abciximab efficacy determined

Central Drug Research Institute, Lucknow - Thiazolidinedione derivatives with antihyperglycemic activity synthesized

Chang Gung University - SPARC gene shows promise as prognostic marker

ChemoCentryx, Inc. - Phase II clinical trial of Traficet-EN in IBD begins

Chemokine Therapeutics Corp. - Biotech company completes IPO, raises CDN$16M

Chronogen, Inc. - Sosei inks agreement for screening of its Drug Reprofiling Platform library

City University of New York - Global alliance for vaccines not a model for public-private cooperation

Cleveland Clinic Foundation - Recent findings illuminate research in immunology

Corautus Genetics, Inc. - Results of gene-transfer approach to vascular disease using stents published

Corgentech, Inc. - IND filed for phase I/II trial of new drug candidate for eczema

Cornell University, Ithaca - Caco2 cell model used to study bioavailability of whole food phytochemicals

Cyprus Institute of Neurology & Genetics - Star polymers ferry plasmids to cancer cells

DNAX Research Institute, Palo Alto - IL-12 and IL-23 work together to protect host and prevent tumor development

Dana-Farber Cancer Institute - Maytansinoid immunoconjugate B-B4-DM1 kills multiple myeloma cells

Diet & Nutrition - Federal grant funds healthy-choices study in Mount Vernon

Diet & Nutrition - New government guidelines emphasize calories, exercise

Disease Outbreak - United Nations confirms two cases of measles in tsunami-hit Sumatra

Dr. Foster - New figures highlight trends in drug and alcohol misuse

Duke University - Iron deficiency sparks dramatic changes in gene expression

Ege University Hospital - Researchers report details of new studies and findings in the area of oncology

Gemin X Biotechnologies, Inc. - Gemin X Biotechnologies initiates phase I/II clinical trial with GX15-070 in CLL

Genentech, Inc. - Company finalizes Avastin label with previously announced safety information

GlaxoSmithKline - Company announces expanded indication for BEXXAR in NHL

MGI PHARMA, Inc. - Dacogen NDA accepted for filing by U.S. FDA

Noven Pharmaceuticals, Inc. - Drug delivery company submits comments to FDA regarding generic Duragesic

RedPrairie Corporation - Supply chain company supports U.S. FDA food & beverage bioterrorism regulations

RetinaPharma Technologies, Inc - U.S. FDA clearance received for TonoPach enabling easier diagnosis of glaucoma

Selective Micro Technologies - Technology company gets U.S. FDA approval for biocide chlorine dioxide

U.S. Food & Drug Administration - Multiclass methods developed for drug residues in eggs

U.S. National Institutes of Health - Chimpanzee Fab fragments and IgG cross-neutralize dengue viruses

U.S. National Institutes of Health - West Nile Virus-like particles induced sterilizing immunity

Valeant Pharmaceuticals - Company submits response to U.S. FDA approvable letter, appoints new CEO

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook